If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.16    -0.0105 (-6.16%)
Bid:
0.15
Ask:
0.17
Spread: 0.02 (13.333%)
Market Cap: £2.11m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Issue of Equity

5 May 2009 13:00

RNS Number : 6874R
ValiRx PLC
05 May 2009
 



ValiRx plc

(the "Company")

Issue of equity

Following the recent placing of new ordinary shares of 1p each in the Company ("Ordinary Shares"), the Company is pleased to announce that it has received further interest from investors. As a result, the Company has raised an additional amount of up to £200,000, before expenses, via a placing of up to 16,666,666 new Ordinary Shares at 1.2p per share ("Placing Shares").

Application will be made for the Placing Shares to be admitted to trading on AIM and dealings are expected to commence on 11 May, 2009. A further announcement will be released on admission confirming the total number of shares issued.

Enquiries: 

ValiRx plc

Tel: +44 (0) 20 3008 4416

Dr. Satu Vainikka

WH Ireland Limited - Nominated Adviser & Broker

Tel: +44 (0) 161 832 2174

Adrian Kirk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEFELFBKEBZBBB
Date   Source Headline
30th Jan 20257:00 amRNSExtension of Evaluation Agreement
29th Jan 20257:00 amRNSNew Evaluation and Option Agreement
15th Jan 202512:47 pmRNSHolding(s) in Company
15th Jan 202511:29 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
9th Jan 202511:37 amRNSHolding(s) in Company
9th Jan 202511:14 amRNSHolding(s) in Company
8th Jan 20257:00 amRNSHolding(s) in Company
2nd Jan 202511:45 amRNSHolding(s) in Company
31st Dec 20241:06 pmRNSHolding(s) in Company
31st Dec 20248:39 amRNSUpdate on proposed sub-license of VAL201
30th Dec 20241:30 pmRNSResult of GM, Issue of Equity, Warrants and TVR
20th Dec 20247:00 amRNS-RValiRx launches new interactive investor website
10th Dec 20244:45 pmRNSBroker Offer Results & Director/PDMR Subscription
10th Dec 20243:03 pmRNSPosting of Circular and Notice of General Meeting
9th Dec 20247:00 amRNSConditional Fundraising & Launch of Broker Offer
22nd Nov 20247:00 amRNSInaphaea award of HEIF Funding and PhD sponsorship
20th Nov 20247:00 amRNSUpdate on proposed sub-license of VAL401
19th Nov 20247:00 amRNSContract Award
18th Nov 20247:00 amRNSFirst Sale of New Product Line
30th Oct 20247:00 amRNSUpdate on proposed sub-license of VAL201
18th Oct 20247:00 amRNSDirectorate Change
14th Oct 20247:00 amRNSInvestor Webinar
7th Oct 20247:00 amRNSInaphaea Co-Marketing Agreement
27th Sep 20247:00 amRNSHalf-year Report
26th Sep 20247:00 amRNSConclusion of Evaluation Project
24th Sep 20247:00 amRNSInaphaea Co-Marketing Agreement
18th Sep 20247:00 amRNSInaphaea Evaluation and Commercial Use Agreement
16th Sep 20247:00 amRNSInaphaea Co-Marketing Agreement
9th Sep 20247:00 amRNSInaphaea Evaluation and Commercial Use Agreement
9th Sep 20247:00 amRNSInvestor Evening
27th Aug 20247:00 amRNSInaphaea Evaluation and Commercial Use Agreement
12th Aug 20247:00 amRNSDirectorate Change
25th Jul 20247:00 amRNSDirectorate Changes
3rd Jul 20248:51 amRNSProposed Director Appointment
20th Jun 20245:56 pmRNSResult of AGM
19th Jun 202411:33 amRNSDirectorate Change
17th Jun 20247:00 amRNSInaphaea Contract Award
28th May 20247:00 amRNSInvestor Webinar
20th May 202412:00 pmRNSBusiness Update
16th May 20247:00 amRNSFurther re Final Results
15th May 20247:00 amRNSFinal Results and Notice of AGM
22nd Apr 20247:00 amRNSDirectorate Changes
21st Mar 20247:00 amRNSEvaluation Agreement with Imperial College London
19th Mar 20247:00 amRNSBoard Re-structuring and update on requisition
4th Mar 20245:47 pmRNSShareholder Requisition Notice
4th Mar 20247:00 amRNSProposed Appointment of Non-Executive Director
29th Feb 20242:00 pmRNSProposed Appointment of Non-Executive Director
13th Feb 20242:20 pmRNSFurther re Shareholder Requisition Notice
9th Feb 20245:06 pmRNSShareholder Requisition Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.